- Section 1 The Subject Matter of and Approach to Psychiatry
- 1.3 Psychiatry as a worldwide public health problem
- 1.4 The history of psychiatry as a medical specialty
- 1.5 Ethics and values
- 1.6 The psychiatrist as a manager
- 1.7 Descriptive phenomenology
- 1.8 Assessment
- 1.9 Diagnosis and classification
- 1.10 From science to practice
- Section 2 The Scientific Basis of Psychiatric Aetiology
- 2.3 The contribution of neurosciences
- 2.4 The contribution of genetics
- 2.5 The contribution of psychological science
- 2.6 The contribution of social sciences
- 2.7 The contribution of epidemiology to psychiatric aetiology
- Section 3 Psychodynamic Contributions to Psychiatry
- Section 4 Clinical Syndromes of Adult Psychiatry
- 4.1 Delirium, dementia, amnesia, and other cognitive disorders
- 4.1.1 Delirium
- 4.1.2 Dementia: Alzheimer's disease
- 4.1.3 Frontotemporal dementias
- 4.1.4 Prion disease
- 4.1.5 Dementia with Lewy bodies
- 4.1.6 Dementia in Parkinson's disease
- 4.1.7 Dementia due to Huntington's disease
- 4.1.8 Vascular dementia
- 4.1.9 Dementia due to HIV disease
- 4.1.10 The neuropsychiatry of head injury
- 4.1.11 Alcohol-related dementia (alcohol-induced dementia; alcohol-related brain damage)
- 4.1.12 Amnesic syndromes
- 4.1.13 The management of dementia
- 4.1.14 Remediation of memory disorders
- 4.2 Substance use disorders
- 4.3 Schizophrenia and acute transient psychotic disorders
- 4.3.6 Aetiology
- 4.3.7 Course and outcome of schizophrenia and their prediction
- 4.3.8 Treatment and management of schizophrenia
- 4.3.9 Schizoaffective and schizotypal disorders
- 4.3.10 Acute and transient psychotic disorders
- 4.4 Persistent delusional symptoms and disorders
- 4.5 Mood disorders
- 4.6 Stress-related and adjustment disorders
- 4.7 Anxiety disorders
- Section 5 Psychiatry and Medicine
- Section 6 Treatment Methods in Psychiatry
- 6.2 Somatic treatments
- Section 7 Social Psychiatry and Service Provision
- Section 8 The Psychiatry of Old Age
- Section 9 Child and Adolescent Psychiatry
(p. 351) Prion disease
- Chapter:
- (p. 351) Prion disease
- Author(s):
John Collinge
- DOI:
- 10.1093/med/9780199696758.003.0044
The human prion diseases, also known as the subacute spongiform encephalopathies, have been traditionally classified into Creutzfeldt–Jakob disease (CJD), Gerstmann–Sträussler syndrome (GSS) (also known as Gerstmann–Sträussler–Scheinker disease), and kuru. Although rare, affecting about 1–2 per million worldwide per annum, remarkable attention has been recently focused on these diseases. This is because of the unique biology of the transmissible agent or prion, and also because bovine spongiform encephalopathy (BSE), an epidemic bovine prion disease, appears to have transmitted to humans as variant CJD (vCJD), opening the possibility of a significant threat to public health through dietary exposure to infected tissues. The transmissibility of the human diseases was demonstrated with the transmission, by intracerebral inoculation with brain homogenates into chimpanzees, of first kuru and then CJD in 1966 and 1968, respectively. Transmission of GSS followed in 1981. The prototypic prion disease is scrapie, a naturally occurring disease of sheep and goats, which has been recognized in Europe for over 200 years and which is present in the sheep flocks of many countries. Scrapie was demonstrated to be transmissible by inoculation in 1936 and the recognition that kuru, and then CJD, resembled scrapie in its histopathological appearances led to the suggestion that these diseases may also be transmissible. Kuru reached epidemic proportions amongst the Fore linguistic group in the Eastern Highlands of Papua New Guinea and was transmitted by ritual cannibalism. Since the cessation of cannibalism in the 1950s the disease has declined but a few cases still occur as a result of the long incubation periods in this condition, which may exceed 50 years. The term Creutzfeldt–Jakob disease was introduced by Spielmeyer in 1922 bringing together the case reports published by Creutzfeldt and Jakob. Several of these cases would not meet modern diagnostic criteria for CJD and indeed it was not until the demonstration of transmissibility allowed diagnostic criteria to be reassessed and refined that a clear diagnostic entity developed. All these diseases share common histopathological features; the classical triad of spongiform vacuolation (affecting any part of the cerebral grey matter), astrocytic proliferation, and neuronal loss, may be accompanied by the deposition of amyloid plaques.
Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.
Please subscribe or login to access full text content.
If you have purchased a print title that contains an access token, please see the token for information about how to register your code.
For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.
- Section 1 The Subject Matter of and Approach to Psychiatry
- 1.3 Psychiatry as a worldwide public health problem
- 1.4 The history of psychiatry as a medical specialty
- 1.5 Ethics and values
- 1.6 The psychiatrist as a manager
- 1.7 Descriptive phenomenology
- 1.8 Assessment
- 1.9 Diagnosis and classification
- 1.10 From science to practice
- Section 2 The Scientific Basis of Psychiatric Aetiology
- 2.3 The contribution of neurosciences
- 2.4 The contribution of genetics
- 2.5 The contribution of psychological science
- 2.6 The contribution of social sciences
- 2.7 The contribution of epidemiology to psychiatric aetiology
- Section 3 Psychodynamic Contributions to Psychiatry
- Section 4 Clinical Syndromes of Adult Psychiatry
- 4.1 Delirium, dementia, amnesia, and other cognitive disorders
- 4.1.1 Delirium
- 4.1.2 Dementia: Alzheimer's disease
- 4.1.3 Frontotemporal dementias
- 4.1.4 Prion disease
- 4.1.5 Dementia with Lewy bodies
- 4.1.6 Dementia in Parkinson's disease
- 4.1.7 Dementia due to Huntington's disease
- 4.1.8 Vascular dementia
- 4.1.9 Dementia due to HIV disease
- 4.1.10 The neuropsychiatry of head injury
- 4.1.11 Alcohol-related dementia (alcohol-induced dementia; alcohol-related brain damage)
- 4.1.12 Amnesic syndromes
- 4.1.13 The management of dementia
- 4.1.14 Remediation of memory disorders
- 4.2 Substance use disorders
- 4.3 Schizophrenia and acute transient psychotic disorders
- 4.3.6 Aetiology
- 4.3.7 Course and outcome of schizophrenia and their prediction
- 4.3.8 Treatment and management of schizophrenia
- 4.3.9 Schizoaffective and schizotypal disorders
- 4.3.10 Acute and transient psychotic disorders
- 4.4 Persistent delusional symptoms and disorders
- 4.5 Mood disorders
- 4.6 Stress-related and adjustment disorders
- 4.7 Anxiety disorders
- Section 5 Psychiatry and Medicine
- Section 6 Treatment Methods in Psychiatry
- 6.2 Somatic treatments
- Section 7 Social Psychiatry and Service Provision
- Section 8 The Psychiatry of Old Age
- Section 9 Child and Adolescent Psychiatry